A retrospective single institutional analysis of outpatient chemotherapy in patients with cancer during the COVID-19 pandemic-Reference-Cited by-同舟云学术

A retrospective single institutional analysis of outpatient chemotherapy in patients with cancer during the COVID-19 pandemic

Published:2024-08-31 Issue:4 Volume:6 Page:268-272
ISSN:2434-9186
Container-title:Global Health & Medicine
language:en
Short-container-title:GHM

Author:

Shimanuki Yumiko¹,Shimomura Akihiko²,Ogawa Chiaki³,Komuro Masato¹,Terakado Hiroyuki¹,Nishimura Takahiro¹,Shimizu Chikako²

Affiliation:

1. Department of Pharmacy, National Center for Global Health and Medicine, Tokyo, Japan.

2. Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.

3. Department of Pharmacy, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.

Publisher

National Center for Global Health and Medicine (JST)

Link

https://www.jstage.jst.go.jp/article/ghm/6/4/6_2023.01134/_pdf

Reference13 articles.

1. 1. American Society of Clinical Oncology. Cancer Treatment & Supportive Care. https://old-prod.asco.org/covid-resources/patient-care-info/cancer-treatment-supportive-care (accessed June 29, 2023).

2. 2. Joint Collaboration Committee of three cancer-related societies (Japanese Cancer Association, Japanese Association for Cancer Therapy, and Japanese Society of Clinical Oncology) Working Group for Countermeasures against coronavirus (COVID-19) Japan Society of Clinical Oncology, Japanese Cancer Association, and the Japanese Society of Medical Oncology. Cancer care and new coronavirus infection: Q&A for healthcare professionals - Revised 3rd ed. Japanese Society of Medical Oncology. https://www.jsmo.or.jp/news/coronavirus-information/qa_vaccinel_3gakkai.html (accessed August 26, 2023). (in Japanese)

3. 3. Cooksley T, Font C, Scotte F, Escalante C, Johnson L, Anderson R, Rapoport B. Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: A MASCC position paper. Support Care Cancer. 2021; 29:1129-1138.

4. 4. Japanese Society of Clinical Oncology: Guidelines for the treatment of febrile neutropenia (FN), (Revised 2nd Edition, Japanese Society of Clinical Oncology). Nankodo, Tokyo, 2017; pp.6-9. (in Japanese)

5. 5. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J. Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncol. 2020; 21:335-337.